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Case Report Bullous lesions as a manifestation of systemic lupus 
erythematosus in two Mexican teenagers
Marimar Sáez-de-Ocariz*1, Francisco Espinosa-Rosales2, Eduardo López-Corella3 and Beatriz de León-Bojorge3
Abstract
Rarely, systemic lupus erythematosus (SLE) presents with bullous lesions due to severe edema and hydropic 
degeneration of the basal layer, or as a subepidermal blistering disease. Here, we describe two Mexican teenagers, one 
with SLE with blisters and another with bullous SLE. We also discuss the mechanisms and clinical implications of lesion 
formation in patients with SLE and bullae.
Background
Bullous lesions can occur in systemic lupus erythemato-
sus (SLE) as a subepidermal blistering disease [1] or when
severe edema and hydropic degeneration occur in the
basal layer. The latter condition is considered a lupus ery-
thematosus (LE)-specific lesion [2]. The former condition
is a rare disorder characterized by tense fluid-filled vesi-
cles and bulla, with an erythematous or urticarial back-
ground. This condition is very rare in children, with only
eleven cases reported to date [3-13] (Table 1). Here, we
describe two females, aged 13 and 16 years, who pre-
sented with bullous lesions during the course of SLE.
Report of cases
Case 1
A 13-year-old female presented with a macular and vesic-
ular eruption of 3 days duration. On examination, several
1 mm to 2 mm clear or hemorrhagic tense vesicles over
erythematous macules were identified in the left supracil-
liary region and on the neck (Figure 1). Several 10 mm to
20 mm erythematous macules were also present on the
patient's trunk. Both the vesicles and the macules were
pruriginous.
The patient had been diagnosed with SLE and lupus
nephritis 2 months prior to the onset of the dermatosis,
based on hemolytic anemia, lymphopenia, hypocomple-
mentemia [C4 8 mg/dL (15-45), C3 116 mg/dL (83-177)],
proteinuria (2.3 g/day), and positive antinuclear antibod-
ies (1:640, diffuse pattern). She also had positive anti-
dsDNA antibodies, positive anti-Ro antibodies, positive
low titer IgM (26 MPL) and IgG (21GPL) anticardiolipin
antibodies. She was prescribed oral prednisone and
received three methylprednisolone boluses. The current
dermatosis coincided with a new episode of hemolytic
anemia and resolved with slight depigmentation within
10 days, after a fourth methylprednisolone pulse.
Histopathological study of a skin biopsy revealed a sub-
epidermal blister with marked neutrophilic dermal infil-
tration (Figure 2) and a slight perivascular neutrophilic
infiltrate. Direct immunofluorescence showed strong
granular basement membrane zone IgG, IgA, C1q, and
C3 deposition, and moderate granular vessel IgA and C1q
deposits.
The patient did not experience another bullous erup-
tion in the 3 years following that episode. Her SLE has
predominantly been characterized by nephritis and
hematologic disease, which have gradually resolved with
cyclophosphamide, methylprednisolone boluses, and oral
prednisone. During her most recent follow-up exam,
cytotoxic treatment was suspended, oral prednisone was
being tapered and hydroxychloroquine treatment had
commenced.
Case 2
A 16-year-old female presented with a purpuric and
bullous eruption of 7 days duration. On examination, sev-
eral 3 cm to 6 cm nummular purpuric plaques were dis-
seminated on her trunk and extremities. The surface of
each plaque contained a clear-fluid blister (Figure 3).
The patient had been diagnosed with SLE and second-
ary antiphospholipid syndrome (APS) 1 year prior to the
onset of the dermatosis, based on hemolytic autoimmune
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Table 1: Pediatric Cases of Bulllous SLE
Author & Year Sex Age Clinical features Histopathological features
Jacoby & Abraham 19793 Male 15 years Multiple tense vesicles and bullae, 
arising on normal skin on the face, 
chest, axilla and inner arm
Subepidermal blister with 
neutrophils, eosinophils and 
lymphocytes.
DIF¥ IgG depositis in the BMZ£ under 
and around the vesicle
Hall et al 19824 Male 12 years Small vesicles on an erythematous 
base on arms, face, chest and legs.
Subepidermal bullae with 
neutrophilic microabscesses in 
dermal papillary tips.
DIF: linear IgG, IgA, IgM and IgE and 
granular C3 deposits at the 
dermo-epidermal junction.
Kettler et al 19885 Female 8 years Bullous tense eruption over the face, 
hairline, neck, axilla, groin, ankles, 
palms and soles.
Subepidermal bullae with 
neutrophilic infiltrate as well as 
papillary microabscesses adjacent to 
the bulla.
DIF: Granular IgG and C3 deposits at 
the dermo-epidermal junction
Roholt et al 19956 Female 9 years Linear papulovesicular eruption over 
the right dorsal hand and ulnar 
forearm.
Subepidermal split, mixed cellular 
infiltrate with neutrophils.
DIF: strong IgG, IgA and IgM linear 
deposition at the dermo-epidermal 
junction
Shirhama et al 19987 Female 9 years Widespread blisters on the trunk, 
neck, and oral mucosa.
Subepidermal blister with a 
neutrophilic infiltrate in the upper 
dermis.
DIF: linear IgG, IgA and C3 deposition 
at the BMZ.
Chan et al 19998 Female 15 years Numerous tense bulla on her entire 
skin surface
Subepidermal blister, neutrophilic 
infiltrate in papillary dermis and 
blister cavity.
DIF: IgG, IgA and C3 deposits at the 
BMZ.
Nitta Y et al 20029 Male 17 years Disseminated blistering eruption Papillary microabscesses of 
neutrophils and subepidermal 
blisters.
DIF: IgG, IgA, IgM and C3 deposits at 
the BMZ.
Harris-Stith et al 200310 Female 17 years Photodistributed tense bulla on the 
face (lips and ears) and upper torso, 
as well as oral and vaginal erosions
Neutrophil-rich subepidermal bullae.
DIF: IgG, IgM and C3 deposits at the 
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anemia, lymphopenia, thrombocytopenia, proteinuria,
serositis, cutaneous vasculitis, positive antinuclear anti-
bodies, positive antiphospholipid antibodies, and a
thrombus on the inferior cava vein. During the year prior
to the onset of the bullous dermatosis, the patient had
experienced several disease flares associated with persis-
tent lymphopenia, with the main target organs being the
central nervous system (vasculitis), kidney and liver. She
was treated with methylprednisolone and cyclophosph-
amide boluses, as well as warfarin for APS, topiramate for
seizures, and captopril for high blood pressure. During
this period, the patient also developed warfarin skin
necrosis and experienced three different septic events
(due to E. faecium,  Candida sp and  Aspergillus) that
required aggressive antimicrobial treatment and the
replacement of warfarin with low-dose aspirin.
Histopathological examination of the bullous lesions
revealed an atrophic epidermis with marked keratinocyte
Sirka et al 200511 Female 18 years Vesicles on the left retroauricular 
area, left upper eyelid, right axilla, 
chest and abdomen.
Subepidermal bullae with 
neutrophilic microabscesses.
No DIF was performed.
Vijayalkshmi & 
Jayavardhana 200712
Male 10 years Vesicles and bulla on ears, neck, 
shoulders, arms and legs
Subepidermal blister with 
neutrophilic dermal infiltration.
DIF: strong IgG and moderately 
strong IgM, IgA and C3 granular BMZ 
deposition.
Kumar &Agarwal13 Female 13 years Numerous bulla and vesicles on the 
back, abdomen, neck, flexures of the 
arm and groin.
Dermo-epidermal separation and a 
neutrophil-predominant 
inflammatory infiltrate in the upper 
dermis.
DIF: Prominent fluorescence along 
the epidermal basement membrane 
for IgG, IgA, IgM and C3.
¥ DIF = Direct Immunofluorescence; £ BMZ= Basal membrane zone
Table 1: Pediatric Cases of Bulllous SLE (Continued)
Figure 1 Several 1 mm to 2 mm clear and hemorrhagic tense ves-
icles were observed over erythematous macules on the patient's 
neck.
Figure 2 A subepidermal blister with marked neutrophilic der-
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necrosis, as well as severe hydropic degeneration of the
basal layer with blister formation and papillary dermal
edema. Dermis also showed perivascular and periadnexal
mononuclear cell infiltrate and erythrocyte extravasation
(Figure 4).
These lesions of SLE with blisters healed within 3 weeks
with potent topical steroids. For 7 months after the diag-
nosis of SLE with blisters, the patient's condition was well
controlled with progressively decreasing doses of predni-
sone and hydroxychloroquine, in the absence of cyclo-
phosphamide. Despite taking a low dose of prednisone
(0.25 mg/kg/day), the patient developed a pulmonary
complication that was believed to be the result of sepsis.
The patient later presented with pulmonary hemorrhage
and death. Because all cultures were negative and aspirin
had been inadvertently withdrawn several weeks before,
it is not clear whether the final complication was due to a
massive pulmonary thromboembolism or to septic shock.
Discussion
Blistering eruptions are rare cutaneous manifestations of
SLE that can result from two distinct mechanisms, as
illustrated by the two patients described here. In the first
case, vesicles resulted from a subepidermal blistering dis-
ease with an acute neutrophil-predominant infiltrate in
the upper dermis, known as bullous SLE [1,13]. In the
second case, blisters developed from hydropic degenera-
tion of the basal layer and severe edema in the upper der-
mis, also referred to as SLE with blisters [1,14].
Bullous SLE is a rare, transient autoimmune bullous
disease that occurs in established cases of SLE [11]. It
appears in less than 5% of patients with SLE, either in iso-
lation or in addition to other cutaneous manifestations
[15]. This condition usually affects young females, with
only eleven cases reported in children [3-13] until now.
The association of bullous SLE with lupus nephritis has
been reported in adults [15-17]. It appears that the close
relationship between bullous SLE and lupus nephritis is
also important in children, as demonstrated by Sirka et al
[11], Vijayalakshmi and Jayavardhana [12], Kumar and
Agarwal [13], and the first of the two cases presented
here.
The relationship between lupus nephritis and bullous
SLE does not appear to be casual. Onetti Muda et. al [18]
demonstrated that type VII collagen, which is usually not
present in normal glomeruli, is actively synthesized and
incorporated in areas of glomerular and/or tubular scar-
ring, irrespective of the underlying disease (including SLE
nephritis). These findings confirm the de novo expression
of fibrillary collagens in the diseased renal extracellular
matrix.
Systemic lupus erythematosus is a multisystem hetero-
geneous autoimmune disease and auto-antibodies
directed against several components of the cell have been
described. It can be hypothesized that bullous SLE devel-
ops in patients with lupus nephritis once type VII colla-
gen deposition has occurred in an abnormal location
(e.g., the kidney) and antibody production towards this
abnormally located protein has been initiated. Type VII
collagen is the major component of anchoring fibrils at
the dermal-epidermal junction, and is the target of auto-
immunity in patients with bullous SLE [19]. There has
Figure 4 Epidermis with keratinocyte necrosis, severe basal liq-
uefaction degeneration with blister formation and papillary der-
mal edema.
Figure 3 A purpuric plaque with clear-fluid blisters on the sur-
face.Sáez-de-Ocariz et al. Pediatric Rheumatology 2010, 8:19
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been at least one report of bullous eruption as the first
clinical sign of SLE relapse [20] suggesting that skin dam-
age can be a marker of disease activity.
The second patient described in this report developed
SLE with blisters, which is also a rare manifestation of
SLE both in adults and children. The actual incidence of
this condition is difficult to ascertain, especially because
some cases are reported under the term 'bullous SLE',
even when the patients do not have the typical autoim-
mune blistering disease with acute neutrophilic upper
dermal infiltrate and subepidermal separation, as well as
positive direct immunofluorescence tests. However, of
the 148 pediatric SLE cases that have been examined in
our lupus clinic over the last 8 years, this is our first inci-
dence of SLE with blisters.
As opposed to bullous SLE, SLE with blisters has not
been associated with specific systemic lupus manifesta-
tions and therefore does not necessarily imply a worse
prognosis. This LE-specific lesion represents a severe
dermo-epidermal edema, which is not directed towards
specific antigens.
The differential diagnosis of blistering eruptions in
patients with SLE includes dermatitis herpetiformis and
bullous pemphigoid which are clinically similar but can
be differentiated by direct immunofluorescence. Bullous
lesions in SLE due to photosensitivity, acute lupus or
drugs can be differentiated by both histopathology and
immunopathology. Epidermolysis bullosa acquisita (EBA)
is histopathologically and immunopathologically identi-
cal since both are mediated by circulating antibodies
against type VII collagen. However, a dramatic therapeu-
tic response to dapsone in bullous SLE differentiates it
from EBA [11]. When in a linear disposition, herpes
zoster can be considered in the differential, but it can be
easily differentiated by histopathology [6].
It seems contradictory that the patient with bullous SLE
continued to thrive, whereas the patient with SLE with
blisters, which are apparently not associated with any fur-
ther risk, had a fatal clinical course. However, the cause of
death in the latter case could be related to an APS relapse
when the patient developed what has been called "cata-
strophic APS" after low-dose aspirin was inadvertently
withdrawn. There were no other signs or symptoms of
SLE disease activity, cyclophosphamide had been
stopped, and the prednisone dose was low. Therefore, the
patient had a low risk of developing a septic event due to
the immunosuppressive effects of medical treatment.
Conclusions
The recognition and correct diagnosis of two different
mechanisms of blistering production in SLE is manda-
tory, as bullous SLE implies the risk of lupus nephritis and
can sometimes be the first manifestation of the disease
[16,21], whereas SLE with blisters does not generally
imply further risk of disease activity or a bad prognosis.
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